Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC2683778

Invivogen R848 (Resiquimod), Dual TLR7/TLR8 Agonist, Lyophilized Powder, 1 mg
SDP

Catalog No. NC2683778
Encompass

InvivoGen's R848 (Resiquimod) is a potent TLR7/TLR8 agonist, ideal for immunological research. Supplied as a lyophilized powder in two 500 µg vials, it activates immune cells, enhancing pro-inflammatory cytokine production. Its rigorous testing ensures no contamination with TLR2 or TLR4, making it a reliable tool for studying antiviral and antibacterial immunity, along with vaccine development.

Catalog No. NC2683778 Supplier Invivogen Supplier No. TLRLR8481
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

InvivoGen's R848 (Resiquimod) is a potent TLR7/TLR8 agonist, ideal for immunological research. Supplied as a lyophilized powder in two 500 µg vials, it activates immune cells, enhancing pro-inflammatory cytokine production. Its rigorous testing ensures no contamination with TLR2 or TLR4, making it a reliable tool for studying antiviral and antibacterial immunity, along with vaccine development.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.